Work

Poly-ICLC as an adjuvant for NY-ESO-1 protein vaccination with or without Montanide ISA-51 VG in patients with melanoma.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e14034

Authors: Rachel Lubong Sabado, Anna C. Pavlick, Sacha Gnjatic, Farah Hasan, Meredith Spadaccia, Bike Su Oner, Hanqing Dong, Rose Marie Holman, Isabelita Vengco, Caroline Muren, Crystal Escano, Ethel Yepes, Claire Stein, Achim A Jungbluth, Linda S. Pan, Ralph Rudolph Venhaus, Andres M. Salazar, Patrick Alexander Ott, Nina Bhardwaj

Institutions: Icahn School of Medicine at Mount Sinai, New York University, Ludwig Cancer Research, Oncovir (United States), Dana-Farber Cancer Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2738528757

Cites:

Cited by:

Related to: 10